FDA Clarifies Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act

June 28, 2023

Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products

May 15, 2023

FDA Announces Impact of Ending COVID-19 Public Health Emergency

March 16, 2023

FDA Launches New Directory of Ingredients Used in Products Marketed as Dietary Supplements

March 13, 2023

FDA Launches New Directory of Ingredients Used in Products Marketed as Dietary Supplements

March 7, 2023

Discounted Drugs under the 340B Program

December 20, 2022

Note of Caution to Compounding Pharmacies

December 20, 2022

Considerations for 3D Printing of Medical Devices, Accessories, Components and Parts During the COVID-19 Pandemic

April 13, 2020